Table 1.
Paris | London | Geneva | Lisbon | Lisbon | Roma | Barcelona | Kyoto | |
---|---|---|---|---|---|---|---|---|
Device (Tesla) | 1.5 | 1.5/3.0 | 3.0 | 1.5 | 1.5/3.0 | 3.0 | 1.5/3.0 | 1.5/3.0 |
Phased-array | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Endocavitary probe | No | No | No | No | No | No | No | No |
Timing of MRI | No | No | > Day 8 | No | No | No | No | No |
Fasting | 3h | No | 6h | 6h | 4h | 6h | 4h | 4h |
Special diet | No | No | No | No | No | No | No | No |
Bowel enema | Yes | No | Yes | No | Yes | Yes | No | No |
Bladder emptying | 2h | No | No | 2h | 1h | 1h | No | No |
IV catheter | No (Option) | Yes | Yes | Yes | Yes | Yes | Yes | No |
Anti-peristaltic agent | SC | IV | IM | IV | IV | IV | IV | SC |
Belt strapping | Yes | No | Yes | Yes | No | No | No | Yes |
Vaginal opacification | No | No | Yes* | Yes* | Yes* | No | No | No |
Rectal opacification | No | Yes | Yes* | Yes* | Yes* | Yes* | No | No |
Supine position | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Prone position | Yes** | No | No | No | No | No | No | No |
IM intramuscular, IV intravenous, SC subcutaneous
* If doubt or symptoms present (i.e. dyspareunia, dyschezia)
**If claustrophobic